Cargando…

Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) increases the risk of Alzheimer’s disease (AD)-like dementia and pathology. Endoplasmic reticulum stress (ERS) plays a key role in the development of cognitive impairment in T2DM. Zonisamide (ZNS) was found to suppress ERS-induced neuronal cell damage in the experimen...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yong-Xiang, Shen, Qi-Ying, Tian, Jia-Hui, Wu, Qian, Xue, Qin, Zhang, Gui-Ping, Wei, Wei, Liu, Ying-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367218/ https://www.ncbi.nlm.nih.gov/pubmed/32754028 http://dx.doi.org/10.3389/fnagi.2020.00192

Ejemplares similares

Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models
por: Tada, Satoshi, et al.
Publicado: (2022)

Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model
por: Kanbara, Shunsuke, et al.
Publicado: (2020)

Effect of topiramate and zonisamide on fMRI cognitive networks
por: Wandschneider, Britta, et al.
Publicado: (2017)

Zonisamide in the management of epilepsy in the elderly
por: Romigi, Andrea, et al.
Publicado: (2015)

Impact of Pregnancy on Zonisamide Pharmacokinetics in Rabbits
por: Matar, Kamal M.
Publicado: (2013)

Repositioning again of zonisamide for nerve regeneration
por: Ohno, Kinji, et al.
Publicado: (2016)

Zonisamide-induced acute kidney injury
por: Dixit, Deepali, et al.
Publicado: (2015)

Efficacy of Zonisamide in Migraineurs with Nonresponse to Topiramate
por: Chung, Jin-Young, et al.
Publicado: (2014)

Zonisamide-Induced Hallucinations: An Anticonvulsant’s Psychosis
por: Al Armashi, Abdul Rahman, et al.
Publicado: (2021)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)

Zonisamide is effective in the preventive therapy of chronic migraine
por: Belvis, R, et al.
Publicado: (2013)

Probable drug-induced lupus erythematosus by zonisamide
por: Safadi, Mohannad G., et al.
Publicado: (2021)

Zonisamide – a review of experience and use in partial seizures
por: Wilfong, Angus A, et al.
Publicado: (2006)

Update on once-daily zonisamide monotherapy in partial seizures
por: Afra, Pegah, et al.
Publicado: (2014)

Silicate Urolithiasis during Long-Term Treatment with Zonisamide
por: Taguchi, Satoru, et al.
Publicado: (2013)

Zonisamide Efficacy as Adjunctive Therapy in Children With Refractory Epilepsy
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Limited efficacy of zonisamide in the treatment of refractory infantile spasms
por: Hussain, Shaun A., et al.
Publicado: (2020)

The Effect of Zonisamide and Ethanol on Various Types of Memory in Rats
por: Pietrzak, Bogusława, et al.
Publicado: (2023)

GLYX-13 pretreatment ameliorates long-term isoflurane exposure-induced cognitive impairment in mice
por: Liu, Huan, et al.
Publicado: (2019)

Isorhynchophylline ameliorates stress-induced emotional disorder and cognitive impairment with modulation of NMDA receptors
por: Wang, Chen, et al.
Publicado: (2022)

Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational Study
por: Ramirez-García, Teresa, et al.
Publicado: (2016)

Zonisamide Changes Unilateral Cortical Excitability in Focal Epilepsy Patients
por: Joo, Eun Yeon, et al.
Publicado: (2010)

HPLC Method for Simultaneous Determination of Impurities and Degradation Products in Zonisamide
por: Vijayakumar, E. K. S., et al.
Publicado: (2009)

Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients
por: Park, Sung-Pa, et al.
Publicado: (2007)

Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson's Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2012)

Pharmacokinetics of Single‐Dose Rectal Zonisamide Administration in Normal Dogs
por: Brewer, D.M., et al.
Publicado: (2015)

Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
por: Vivar, Karina L., et al.
Publicado: (2017)

Zonisamide effects on sleep problems and depressive symptoms in Parkinson’s disease
por: Suzuki, Keisuke, et al.
Publicado: (2021)

Mild endoplasmic reticulum stress ameliorates lipopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial polarization
por: Wang, Yi-wei, et al.
Publicado: (2017)

Correction to: Mild endoplasmic reticulum stress ameliorates lipopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial polarization
por: Wang, Yi-wei, et al.
Publicado: (2020)

PQQ ameliorates D-galactose induced cognitive impairments by reducing glutamate neurotoxicity via the GSK-3β/Akt signaling pathway in mouse
por: Zhou, Xing-qin, et al.
Publicado: (2018)

Zonisamide Decreases Current-Source Density of High Beta Frequency of Electroencephalogram
por: Kwon, Oh-Young, et al.
Publicado: (2013)

Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults
por: Mula, Marco
Publicado: (2013)

Open Label Trial of the Tolerability and Efficacy of Zonisamide in the Treatment of Alcohol Dependence
por: Knapp, Clifford M., et al.
Publicado: (2010)

Comparative Efficacy of Zonisamide and Pregabalin as an Adjunctive Therapy in Children with Refractory Epilepsy
por: TAGHDIRI, Mohammad Mahdi, et al.
Publicado: (2015)

Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders
por: Knapp, Clifford M., et al.
Publicado: (2015)

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

Hepatocellular necrosis with prominent regenerative reactions in a zonisamide administrated dog
por: TAKAMI, Yuki, et al.
Publicado: (2020)

Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide
por: Naito, Tatsuhiko, et al.
Publicado: (2022)

Polysomnographic and Clinical Parameters before and after Zonisamide Therapy for Parkinson's Disease
por: Miyaue, Noriyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_14kidg58v3eia2vgar74u5eeec